HQY HEALTHEQUITY INC revenue, earnings and financials

For the quarter ended July 31, 2026, HEALTHEQUITY INC reported revenue of $351M (up 7.6% from a year earlier), net income of $65.6M and diluted EPS of $0.78; over the last four quarters revenue was $1.36B and net income $236M; for the fiscal year ended January 2026 revenue was $1.31B, up 9.5% on the year before.

HQY annual revenue and earnings

• Fiscal year ended Jan 2026: revenue $1.31B, gross profit $913M, operating income $322M, net income $215M (margin 16.4%), EPS $2.46
• Fiscal year ended Jan 2025: revenue $1.20B, gross profit $777M, operating income $162M, net income $96.7M (margin 8.1%), EPS $1.09
• Fiscal year ended Jan 2024: revenue $1000M, gross profit $623M, operating income $118M, net income $55.7M (margin 5.6%), EPS $0.64
• Fiscal year ended Jan 2023: revenue $862M, gross profit $492M, operating income $9.06M, net income −$26.1M (margin -3.0%), EPS −$0.31
• Fiscal year ended Jan 2022: revenue $757M, gross profit $425M, operating income −$24.2M, net income −$44.3M (margin -5.9%), EPS −$0.53

HQY quarterly revenue and earnings

• Quarter ended Jul 31, 2026: revenue $351M (up 7.6% year over year), net income $65.6M, EPS $0.78
• Quarter ended Apr 30, 2026: revenue $355M (up 7.2% year over year), net income $69.4M, EPS $0.82
• Quarter ended Jan 31, 2026 (from the annual report): revenue $335M (up 7.3% year over year), net income $49.7M, EPS $0.58
• Quarter ended Oct 31, 2025: revenue $322M (up 7.2% year over year), net income $51.7M, EPS $0.59
• Quarter ended Jul 31, 2025: revenue $326M (up 8.6% year over year), net income $59.9M, EPS $0.68
• Quarter ended Apr 30, 2025: revenue $331M (up 15.0% year over year), net income $53.9M, EPS $0.61
• Quarter ended Jan 31, 2025 (from the annual report): revenue $312M (up 18.8% year over year), net income $26.4M, EPS $0.30
• Quarter ended Oct 31, 2024: revenue $300M (up 20.5% year over year), net income $5.70M, EPS $0.06
• Quarter ended Jul 31, 2024: revenue $300M (up 23.1% year over year), net income $35.8M, EPS $0.40
• Quarter ended Apr 30, 2024: revenue $288M (up 17.7% year over year), net income $28.8M, EPS $0.33
• Quarter ended Jan 31, 2024: revenue $262M (up 12.2% year over year), net income $26.4M, EPS $0.30
• Quarter ended Oct 31, 2023: revenue $249M (up 15.3% year over year), net income $14.7M, EPS $0.17
• Quarter ended Jul 31, 2023: revenue $244M (up 18.1% year over year), net income $10.6M, EPS $0.12
• Quarter ended Apr 30, 2023: revenue $244M (up 18.8% year over year), net income $4.09M, EPS $0.05
• Quarter ended Jan 31, 2023: revenue $234M (up 15.0% year over year), net income −$209K, EPS $0.00
• Quarter ended Oct 31, 2022: revenue $216M (up 20.1% year over year), net income −$1.64M, EPS −$0.02
• Quarter ended Jul 31, 2022: revenue $206M (up 9.0% year over year), net income −$10.7M, EPS −$0.13
• Quarter ended Apr 30, 2022: revenue $206M (up 11.7% year over year), net income −$13.6M, EPS −$0.16
• Quarter ended Jan 31, 2022: revenue $203M, net income −$32.8M, EPS −$0.39
• Quarter ended Oct 31, 2021: revenue $180M, net income −$5.04M, EPS −$0.06

HQY cash flow, buybacks and dividends

• Fiscal year ended Jan 2026: operating cash flow $457M, share buybacks $299M
• Fiscal year ended Jan 2025: operating cash flow $340M, share buybacks $121M
• Fiscal year ended Jan 2024: operating cash flow $243M, share buybacks $0
• Fiscal year ended Jan 2023: operating cash flow $151M, share buybacks $0
• Fiscal year ended Jan 2022: operating cash flow $141M, share buybacks n/a

HQY balance sheet

• Jul 31, 2026: cash $256M, total assets $3.27B, total liabilities $1.28B, shareholders' equity $1.99B, long-term debt $931M
• Apr 30, 2026: cash $265M, total assets $3.31B, total liabilities $1.26B, shareholders' equity $2.05B, long-term debt $943M
• Jan 31, 2026: cash $319M, total assets $3.38B, total liabilities $1.27B, shareholders' equity $2.11B, long-term debt $957M
• Oct 31, 2025: cash $309M, total assets $3.40B, total liabilities $1.26B, shareholders' equity $2.13B, long-term debt $982M
• Jul 31, 2025: cash $304M, total assets $3.42B, total liabilities $1.27B, shareholders' equity $2.15B, long-term debt $1.01B
• Apr 30, 2025: cash $288M, total assets $3.42B, total liabilities $1.29B, shareholders' equity $2.12B, long-term debt $1.06B
• Jan 31, 2025: cash $296M, total assets $3.45B, total liabilities $1.33B, shareholders' equity $2.11B, long-term debt $1.06B
• Oct 31, 2024: cash $322M, total assets $3.49B, total liabilities $1.36B, shareholders' equity $2.12B, long-term debt $1.08B

What is HQY's revenue?

HEALTHEQUITY INC reported $1.36B of revenue over its last four quarters, through July 31, 2026.

Is HQY profitable?

Yes. HEALTHEQUITY INC earned $236M over the last four quarters.

What is HQY's EPS?

Diluted earnings per share over the last four quarters were $2.77; $0.78 in the latest quarter.

HQY ownership and insider trades · All stocks